Kerry-Anne Rye Selected Research

Atorvastatin (Lipitor)

12/2022	Atorvastatin improves cisplatin sensitivity through modulation of cholesteryl ester homeostasis in breast cancer cells.
1/2019	High plasma FGF21 levels predicts major cardiovascular events in patients treated with atorvastatin (from the Treating to New Targets [TNT] Study).
1/2018	Effect of atorvastatin, cholesterol ester transfer protein inhibition, and diabetes mellitus on circulating proprotein subtilisin kexin type 9 and lipoprotein(a) levels in patients at high cardiovascular risk.
5/2014	Effect of change in body weight on incident diabetes mellitus in patients with stable coronary artery disease treated with atorvastatin (from the treating to new targets study).
11/2012	Relationship between atorvastatin dose and the harm caused by torcetrapib.
5/2012	Plasma PCSK9 levels and clinical outcomes in the TNT (Treating to New Targets) trial: a nested case-control study.
8/2011	Effect of torcetrapib on glucose, insulin, and hemoglobin A1c in subjects in the Investigation of Lipid Level Management to Understand its Impact in Atherosclerotic Events (ILLUMINATE) trial.
11/2009	Regulatory effects of fenofibrate and atorvastatin on lipoprotein A-I and lipoprotein A-I:A-II kinetics in the metabolic syndrome.
11/2006	Effects of atorvastatin and apoA-I/phosphatidylcholine discs on triglyceride-rich lipoprotein subfractions as characterized by capillary isotachophoresis.
11/2005	Impact of short-term administration of high-density lipoproteins and atorvastatin on atherosclerosis in rabbits.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kerry-Anne Rye Research Topics

Disease

46	Atherosclerosis 02/2024 - 06/2002
39	Cardiovascular Diseases (Cardiovascular Disease) 02/2024 - 06/2005
39	Inflammation (Inflammations) 01/2023 - 01/2008
23	Insulin Resistance 01/2023 - 03/2006
22	Type 2 Diabetes Mellitus (MODY) 07/2021 - 03/2009
9	Obesity 01/2023 - 11/2009
9	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2019 - 03/2006
8	Coronary Disease (Coronary Heart Disease) 01/2021 - 01/2009
7	Coronary Artery Disease (Coronary Atherosclerosis) 01/2018 - 05/2010
6	Dyslipidemias (Dyslipidemia) 01/2021 - 01/2008
5	Body Weight (Weight, Body) 01/2023 - 05/2014
5	Diabetes Mellitus 01/2018 - 08/2011
4	Hypertriglyceridemia 01/2023 - 03/2006
4	Weight Loss (Weight Reduction) 01/2023 - 11/2007
4	Heart Failure 01/2023 - 11/2012
4	Ischemia 01/2020 - 04/2007
4	Hyperplasia 11/2019 - 04/2013
3	Hypercholesterolemia 12/2023 - 06/2014
3	Chronic Renal Insufficiency 01/2023 - 01/2019
3	Necrosis 01/2022 - 08/2009
3	Myocardial Infarction 01/2021 - 07/2011
3	Atherosclerotic Plaque (Atheroma) 01/2021 - 07/2011
3	Non-alcoholic Fatty Liver Disease 01/2020 - 01/2013
3	Alzheimer Disease (Alzheimer's Disease) 01/2018 - 05/2005
3	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 08/2015 - 02/2008
2	Disease Progression 12/2023 - 01/2021
2	Hyperglycemia 01/2023 - 02/2019
2	Hypertrophy 01/2022 - 06/2012
2	Adenocarcinoma 12/2020 - 01/2016
2	Kidney Diseases (Kidney Disease) 02/2019 - 04/2014
2	Chronic Kidney Failure (Chronic Renal Failure) 02/2019 - 04/2014
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2019 - 01/2013
2	Gestational Diabetes (Gestational Diabetes Mellitus) 01/2019 - 01/2019
2	Pre-Eclampsia (Preeclampsia) 01/2017 - 03/2014
2	Hypertension (High Blood Pressure) 01/2017 - 11/2012
2	Overweight 01/2016 - 01/2008
2	Arteritis 01/2016 - 01/2008
2	Hepatocellular Carcinoma (Hepatoma) 10/2014 - 12/2004

Drug/Important Bio-Agent (IBA)

45	HDL LipoproteinsIBA 01/2022 - 10/2004
40	Apolipoprotein A-I (Apolipoprotein A1)IBA 12/2023 - 06/2004
34	CholesterolIBA 01/2024 - 06/2004
26	LipidsIBA 01/2024 - 09/2006
19	fibroblast growth factor 21IBA 02/2024 - 12/2012
19	ApolipoproteinsIBA 01/2022 - 03/2006
19	HDL CholesterolIBA 01/2021 - 03/2006
16	Biomarkers (Surrogate Marker)IBA 01/2023 - 12/2012
15	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 05/2011
15	Lipoproteins (Lipoprotein)IBA 01/2022 - 10/2004
11	Apolipoproteins E (ApoE)IBA 01/2021 - 06/2004
11	Cholesterol Ester Transfer ProteinsIBA 11/2019 - 06/2005
10	Atorvastatin (Lipitor)FDA Link 12/2022 - 11/2005
10	oxidized low density lipoproteinIBA 12/2022 - 05/2007
9	Insulin (Novolin)FDA Link 12/2023 - 11/2009
9	Proteins (Proteins, Gene)FDA Link 01/2020 - 09/2006
8	Fenofibrate (CiL)FDA LinkGeneric 07/2021 - 09/2006
8	Triglycerides (Triacylglycerol)IBA 01/2021 - 12/2004
6	MicroRNAs (MicroRNA)IBA 01/2021 - 02/2014
5	LDL Lipoproteins (beta Lipoproteins)IBA 12/2022 - 12/2011
5	LDL CholesterolIBA 01/2022 - 12/2011
4	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2024 - 11/2005
4	Phosphatidylcholines (Phosphatidylcholine)IBA 01/2022 - 11/2006
4	baysilon (polydimethylsiloxane)IBA 01/2022 - 01/2008
4	ATP-Binding Cassette Transporters (ABC Transporters)IBA 12/2016 - 02/2007
4	Proprotein Convertase 9IBA 04/2016 - 02/2008
4	LDL Receptors (LDL Receptor)IBA 01/2016 - 02/2008
3	Lipoprotein(a)IBA 01/2021 - 04/2016
3	Apolipoprotein A-II (Apolipoprotein A2)IBA 12/2020 - 08/2010
3	Messenger RNA (mRNA)IBA 01/2020 - 03/2014
3	anacetrapibIBA 11/2019 - 03/2015
3	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 12/2017 - 04/2007
3	CytokinesIBA 12/2017 - 08/2009
3	SphingomyelinsIBA 01/2017 - 05/2007
3	C-Reactive ProteinIBA 04/2015 - 05/2004
3	torcetrapibIBA 11/2012 - 08/2011
3	Apolipoprotein B-100 (Apo B 100)IBA 11/2009 - 09/2006
3	Serine (L-Serine)FDA Link 08/2008 - 05/2007
3	thermozymocidin (myriocin)IBA 08/2008 - 05/2007
3	TransferasesIBA 08/2008 - 05/2007
2	Cholesterol Esters (Cholesteryl Esters)IBA 12/2022 - 01/2022
2	Androgen Receptors (Androgen Receptor)IBA 01/2022 - 01/2022
2	AndrogensIBA 01/2022 - 01/2022
2	Apolipoproteins AIBA 01/2022 - 01/2020
2	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 01/2021 - 11/2007
2	Fatty Acid-Binding ProteinsIBA 11/2020 - 12/2012
2	HomocysteineIBA 11/2020 - 09/2006
2	MetalsIBA 01/2019 - 01/2016
2	Trinitrotoluene (TNT)IBA 01/2019 - 05/2014
2	Advanced Glycation End ProductsIBA 01/2018 - 01/2017
2	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 07/2017 - 12/2011
2	AlbuminsIBA 01/2017 - 11/2016
2	IsotopesIBA 06/2016 - 11/2007
2	Apolipoprotein C-IIIIBA 04/2016 - 01/2016
2	Apolipoproteins B (ApoB)IBA 04/2016 - 09/2006
2	Cell Adhesion MoleculesIBA 01/2016 - 06/2002
2	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 01/2016 - 01/2012
2	CalciumIBA 08/2015 - 10/2014

Therapy/Procedure

11	Therapeutics 08/2022 - 06/2005
6	Glycemic Control 01/2023 - 08/2011
2	Drug Therapy (Chemotherapy) 01/2023 - 12/2022
2	Stents 12/2017 - 04/2013